Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | NVP-TAE684 | 0.31623 | uM | 3 | 2500.00 | 1321.92 | 4025.33 | 3839.67 | 1.0482 | 1.0620 |
| BT-20 | NVP-TAE684 | 1 | uM | 3 | 2500.00 | 1321.92 | 3536.33 | 3839.67 | 0.9220 | 0.8972 |
| BT-20 | NVP-TAE684 | 3.1623 | uM | 3 | 2500.00 | 1321.92 | 1650.67 | 3839.67 | 0.4309 | 0.1552 |
| BT-20 | NVP-TAE684 | 10 | uM | 3 | 2500.00 | 1321.92 | 1262.00 | 3839.67 | 0.3282 | -0.0315 |
| BT-20 | Palbociclib | 0.0033113 | uM | 3 | 2500.00 | 1321.92 | 4070.00 | 4169.92 | 0.9734 | 0.9632 |
| BT-20 | Palbociclib | 0.01 | uM | 3 | 2500.00 | 1321.92 | 4166.33 | 4169.92 | 1.0002 | 1.0011 |
| BT-20 | Palbociclib | 0.031623 | uM | 3 | 2500.00 | 1321.92 | 3857.33 | 4169.92 | 0.9256 | 0.9070 |
| BT-20 | Palbociclib | 0.1 | uM | 3 | 2500.00 | 1321.92 | 3517.00 | 4169.92 | 0.8309 | 0.7653 |
| BT-20 | Palbociclib | 0.31623 | uM | 3 | 2500.00 | 1321.92 | 2716.67 | 4169.92 | 0.6697 | 0.5707 |
| BT-20 | Palbociclib | 1 | uM | 3 | 2500.00 | 1321.92 | 1914.67 | 4169.92 | 0.4600 | 0.2410 |
| BT-20 | Palbociclib | 3.1623 | uM | 3 | 2500.00 | 1321.92 | 1754.00 | 4169.92 | 0.4186 | 0.1693 |
| BT-20 | Palbociclib | 10 | uM | 3 | 2500.00 | 1321.92 | 1584.00 | 4169.92 | 0.3802 | 0.1045 |
| BT-20 | Palbociclib | 19.9526 | uM | 3 | 2500.00 | 1321.92 | 1707.33 | 4169.92 | 0.4123 | 0.1611 |
| BT-20 | Omipalisib | 0.0016596 | uM | 3 | 5000.00 | 2450.33 | 5803.33 | 6184.67 | 0.9374 | 0.9036 |
| BT-20 | Omipalisib | 0.0033113 | uM | 3 | 5000.00 | 2450.33 | 5247.33 | 6184.67 | 0.8490 | 0.7693 |
| BT-20 | Omipalisib | 0.01 | uM | 3 | 5000.00 | 2450.33 | 3863.00 | 6184.67 | 0.6277 | 0.4115 |
| BT-20 | Omipalisib | 0.031623 | uM | 3 | 5000.00 | 2450.33 | 2378.67 | 6184.67 | 0.3869 | -0.0204 |
| BT-20 | Omipalisib | 0.1 | uM | 3 | 5000.00 | 2450.33 | 1802.33 | 6184.67 | 0.2928 | -0.2057 |
| BT-20 | Omipalisib | 0.31623 | uM | 3 | 5000.00 | 2450.33 | 1602.00 | 6184.67 | 0.2602 | -0.2738 |
| BT-20 | Omipalisib | 1 | uM | 3 | 5000.00 | 2450.33 | 1420.67 | 6184.67 | 0.2293 | -0.3378 |
| BT-20 | Omipalisib | 3.1623 | uM | 3 | 5000.00 | 2450.33 | 774.67 | 6184.67 | 0.1256 | -0.5787 |
| BT-20 | Omipalisib | 10 | uM | 3 | 5000.00 | 2450.33 | 948.67 | 6184.67 | 0.1527 | -0.5113 |
| BT-20 | Methotrexate | 0.0016596 | uM | 3 | 5000.00 | 2450.33 | 6419.33 | 6184.67 | 1.0343 | 1.0438 |
| BT-20 | Methotrexate | 0.0033113 | uM | 3 | 5000.00 | 2450.33 | 5824.67 | 6184.67 | 0.9428 | 0.9141 |
| BT-20 | Methotrexate | 0.01 | uM | 3 | 5000.00 | 2450.33 | 6257.67 | 6184.67 | 1.0094 | 1.0094 |